Bukwang Pharmaceutical Co., Ltd.

KOSE:A003000 Stock Report

Market Cap: ₩335.4b

Bukwang Pharmaceutical Dividends and Buybacks

Dividend criteria checks 0/6

Bukwang Pharmaceutical does not currently pay a dividend.

Key information

0%

Dividend yield

1.0%

Buyback Yield

Total Shareholder Yield1.0%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per share₩100.000
Payout ratio0%

Recent dividend and buyback updates

Recent updates

Bukwang Pharmaceutical Co., Ltd.'s (KRX:003000) Popularity With Investors Is Under Threat From Overpricing

Jan 09
Bukwang Pharmaceutical Co., Ltd.'s (KRX:003000) Popularity With Investors Is Under Threat From Overpricing

Bukwang Pharmaceutical (KRX:003000) Has Debt But No Earnings; Should You Worry?

Nov 13
Bukwang Pharmaceutical (KRX:003000) Has Debt But No Earnings; Should You Worry?

Is Bukwang Pharmaceutical (KRX:003000) Weighed On By Its Debt Load?

May 22
Is Bukwang Pharmaceutical (KRX:003000) Weighed On By Its Debt Load?

Investors In Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Should Consider This, First

Apr 03
Investors In Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Should Consider This, First

Did Bukwang Pharmaceutical's (KRX:003000) Share Price Deserve to Gain 71%?

Mar 08
Did Bukwang Pharmaceutical's (KRX:003000) Share Price Deserve to Gain 71%?

Is Bukwang Pharmaceutical (KRX:003000) A Risky Investment?

Feb 10
Is Bukwang Pharmaceutical (KRX:003000) A Risky Investment?

How Much Of Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Do Insiders Own?

Jan 14
How Much Of Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Do Insiders Own?

Does It Make Sense To Buy Bukwang Pharmaceutical Co., Ltd. (KRX:003000) For Its Yield?

Dec 19
Does It Make Sense To Buy Bukwang Pharmaceutical Co., Ltd. (KRX:003000) For Its Yield?

Did You Miss Bukwang Pharmaceutical's (KRX:003000) 90% Share Price Gain?

Nov 23
Did You Miss Bukwang Pharmaceutical's (KRX:003000) 90% Share Price Gain?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if A003000's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A003000's dividend payments have been increasing.

Dividend Yield vs Market

Bukwang Pharmaceutical Dividend Yield vs Market
How does A003000 dividend yield compare to the market?
SegmentDividend Yield
Company (A003000)0%
Market Bottom 25% (KR)1.2%
Market Top 25% (KR)4.0%
Industry Average (Pharmaceuticals)1.0%
Analyst forecast (A003000) (up to 3 years)n/a

Notable Dividend: Unable to evaluate A003000's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A003000's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: A003000 is not paying a notable dividend for the KR market.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A003000 has not reported any payouts.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/13 07:07
End of Day Share Price 2025/01/13 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bukwang Pharmaceutical Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jin Kyun LimIBK Securities Co. Ltd.
JongHoon LeeMirae Asset Securities Co., Ltd. (Pre-Merger)
Seung KimSamsung Securities Co. Ltd.